Full Text View
Tabular View
No Study Results Posted
Related Studies
Image Fusion PET, CT and 3D-Ultrasound Examinations
This study is currently recruiting participants.
Verified by Rigshospitalet, Denmark, March 2007
First Received: March 10, 2006   Last Updated: March 27, 2007   History of Changes
Sponsored by: Rigshospitalet, Denmark
Information provided by: Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT00302094
  Purpose

CT-examinations are used in computer programs which are used in the planning of external radiation of cancers in the anal canal. In CT the structures of the anal canal are hardly visible. 3D-ultrasound examinations offer a better visualisation of normal and pathological structures of the anal canal. The description of the tumour made from the 3D-ultrasound examination is used in the planning of the external radiation.

PET-CT is used to visualise tumour activity also in lymp nodes. The hypothesis of the study is that image fusion of PET, CT and 3D-ultrasound will offer better visualisation of tumour and hereby more accurate diagnostics and treatment.


Condition
Anal Cancer

Study Type: Observational
Study Design: Longitudinal, Defined Population, Prospective Study
Official Title: Image Fusion PET, CT and 3D-Ultrasound Examinations in Treatment of Anal Cancer

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Estimated Enrollment: 40
Study Start Date: June 2006
Estimated Study Completion Date: November 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Histologically verified cancer of the anal canal

Exclusion Criteria:

  • Pregnancy
  • Unability to cooperate to radiation therapy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00302094

Locations
Denmark
Clinic of Radiology, Section of Ultrasound, Rigshospitalet Recruiting
Copenhagen, Denmark, 2100
Contact: Caroline Ewertsen, MD     +45 35 45 35 97     caroline.ewertsen@dadlnet.dk    
Principal Investigator: Caroline Ewertsen, MD            
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Study Director: Michael B Nielsen, Dmsci, phd. Rigshospitalet, Denmark
Principal Investigator: Caroline Ewertsen, MD Rigshospitalet, Denmark
  More Information

No publications provided

Study ID Numbers: (KF) 11-107/03
Study First Received: March 10, 2006
Last Updated: March 27, 2007
ClinicalTrials.gov Identifier: NCT00302094     History of Changes
Health Authority: Denmark: Videnskabsetisk Komité

Study placed in the following topic categories:
Digestive System Neoplasms
Rectal Neoplasms
Gastrointestinal Diseases
Rectal Neoplasm
Intestinal Diseases
Anal Cancer
Rectal Diseases
Intestinal Neoplasms
Digestive System Diseases
Rectal Cancer
Gastrointestinal Neoplasms
Anus Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:
Digestive System Neoplasms
Rectal Neoplasms
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Neoplasms
Anus Neoplasms
Anus Diseases
Colorectal Neoplasms

ClinicalTrials.gov processed this record on September 02, 2009